Urotensin 2 and retinoic acid receptor alpha (RARA) gene expression in IgA nephropathy

Annals of the Academy of Medicine Singapore

Volumn 39, Issue 9, 2010, Pages 705-713

  Woo, Keng Thye ^a   Lau, Yeow Kok ^a   Zhao, Yi ^a   Puong, Kim Yoong ^a   Tan, Hwee Boon ^a   Fook Chong, Stephanie ^a   Wong, Kok Seng ^a   Chan, Choong Meng ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

DNA microarray technology; Genome wide gene expression

Indexed keywords

AMLODIPINE; ATENOLOL; FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 6; PREDNISOLONE; RETINOIC ACID RECEPTOR ALPHA; UNCLASSIFIED DRUG; UROTENSIN II;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; FEMALE; GENE CONTROL; GENE EXPRESSION; HUMAN; HYPERTENSION; IMMUNOGLOBULIN A NEPHROPATHY; MALE; NEPHROTIC SYNDROME; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; UPREGULATION;

EID: 78149275095     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Woo KT, Chiang GS, Pall A, Tan PH, Lau YK, Chin YM. The changing pattern of glomeruloenphritis in Singapore over the past two decades. Clin Nephrol 1999;52:96-102.
2. D'Amico G. The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 1987;245:709-27.
3. Kurella M, Hsiao LL, Yoshida T, Randall JD, Chow G, Sarang SS, et al. DNA microarray analysis of complex biologic processes. J Am Soc Nephrol 2001;12:1072-8.
4. Eikmans M, Baelde HJ, de Heer E, Bruijn JA. RNA expression profiling as prognostic tool in renal patients: toward nephrogenomics. Kidney Int 2002;62:1125-35.
5. Weichert W, Knosel T, Bellach J, Dietel M, Kristiansen G. ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival. J Clin Patho 2004;57:1160-4.
6. Kramer W, Girbig F, Gutjahr U, Kowalewski S, Jouvenal K, Muller G, et al. Intestinal bile acid absorption. Na (+)- dependent bile acid transport activity in rabbit small intestine correlates with the expression of an integral 93-kDa and a peripheral 14-Ida bile acid-binding membrane protein along the duodenum-ileum axis. J Biol Chem 1993;268:18035-46.
7. Johns DG, Ao Z, Naselsky D, Herod CL, Maniscalco K, Sarov-Blat L, et al. Urotensin-II mediated cardiomyocyte hypertrophy: effect of receptor antagonism and role of inflammatory mediators. Arch Pharmacol 2004;370:238-50.
8. Langham RG, Kelly DJ, Gow RM, Zhang Y, Dowling JK, Thomson NM, et al. Increased expression of urotensin II and urotensin II receptor in human diabetic nephropathy. Am J Kidney Dis 2004;44:826-31.
9. Balat A, Pakir IH, Gok F, Anarat R, Sahinoz S. Urotensin-II levels in children with Minimal Change nephrotic syndrome. Pediatr Nephrol 2005;20:42-5.
10. Watson RE, Arjuna Ratnayaka J, Brooke RC, Yee-Sit-Yu S, Ancian P, Griffiths CE. Retinoic acid receptor alpha expression and cutaneous ageing. Mech Ageing Dev 2004;125:465-73.
11. Ribot J, Felipe F, Bonet ML, Palou A. Retinoic acid administration and vitamin A status modulate retinoid X receptor alpha and retinoic acid receptor alpha levels in mouse brown adipose tissue. Mol Cell Biochem 2004;266:25-30.
12. Schaier M, Liebler S, Schade K, Shimizu F, Kawachi H, Grone HJ, et al. Retinoic acid receptor a and retinoid X receptor specific agonists reduce renal injury in established chronic glomerulonephritis of the rat. J Mol Med 2004;82:116-25.
13. Bottinger EP, Ju W, Zavadil J. Applications for microarrays in renal biology and medicine. Exp Nephrol 2002;10:93-101.
14. Barnes MR, Gray IC (eds). Bioinformatics for Geneticists. London: John Wiley & Sons, 2003.
15. Henger A, Kretzler M, Doran P, Bonrouhi M, Schmid H, Kiss E, et al. Gene expression fingerprints in human tubulointerstitial inflammation and fibrosis as prognostic markers of disease progression. Kidney Int 2004;65:904-17.
16. Russo G, Zegar C, Giordano A. Advantages and limitations of microarray technology in humancancer. Oncogene 2003;22:6497-507.
17. Preston GA, Waga I, Alcorta DA, Sasai H, Munger WE, Sullivan P, et al. Gene expression profiles of circulating leukocytes correlate with renal disease activity in IgA nephropathy. Kidney Int 2004;65:420-30.
18. Suzuki H, Suzuki Y, Yamanada T, Hirose S, Nishimura H, Toei J, et al. Genome-wide scan in a novel IgA nephropathy model identifies a susceptibility locus on murine chromosome 10, in a region syntenic to human IgAN1 on chromosome 6q22-23. J Am Soc Nephrol 2005;16:1289-99.